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Background
Decades into the pandemic, the public 
health value of HIV surveillance is 
obvious. Surveillance is traditionally 
depicted as the “radar” or “eyes” of 
public health [1,2]. The World Health 
Organization (WHO) defines it as 
“…ongoing, systematic collection of 
health data, with analysis, evaluation 
and interpretation of these data and 
prompt dissemination of the findings to 
public health officials and others who 
need to know how to help shape public 
health intervention, planning and 
prevention” [2]. Many organizations 
(WHO, the Joint United Nations 
Programme on HIV/AIDS [UNAIDS], 
the European Union, the United States 
Agency for International Development, 
and other bilateral donors) encourage, 
initiate, and fund HIV surveillance 
activities worldwide. 
However, several approaches to 
surveillance remain controversial, 
including the methods used to 
target populations for surveillance, 
the statistical tools through which 
surveillance data are translated into 
HIV incidence data, and, in the light of 
existing, highly effective therapies, the 
obligations of public health agencies to 
identify infected individuals for follow-
up treatment and care. In particular, 
unlinked, anonymous HIV testing 
(UAT), which typically involves the 
use of residual sera normally discarded 
from blood specimens collected from 
persons for routine clinical purposes, 
commonly does not involve obtaining 
consent from the person whose blood 
is tested for HIV. The blood tested for 
HIV is irrevocably anonymized and 
unlinked from the person providing 
the sample and hence the testing 
results cannot be reported back to 
patients. The main reason to waive 
consent is methodological: asking 
persons to volunteer their blood 
samples for HIV testing could lead 
to selection and participation bias 
and compromise the validity of the 
surveillance data [3]. As noted by 
medical historians Bayer [3,4] and 
Fairchild [5], ethical perceptions and 
policies related to UAT in the United 
States underwent a gradual evolution. 
In 1988, UAT without consent was 
considered ethically unproblematic 
by public health officials, lawyers, civil 
liberty activists, and ethicists, and was 
initiated among various population 
groups [6]. But as effective HIV 
treatment and prevention interventions 
became more widespread in the 
1990s, the “unlinked” and “unchosen” 
aspects of UAT came under sharp 
ethical criticism. In the wake of 
dramatic arguments comparing UAT 
at antenatal clinics with the infamous 
Tuskegee syphilis trial, the US Centers 
for Disease Control and Prevention 
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are crucial to guide public health 
interventions, planning, and 
prevention efforts.
sÈ 4HEÈPRACTICEÈOFÈ5!4ÈANÈIMPORTANTÈ
form of HIV surveillance, raises ethical, 
epidemiological, and public health 
challenges in low-income countries.
sÈ 3OMEÈWAYSÈOFÈCONDUCTINGÈ5!4ÈINÈTHEÈ
field violate the spirit and/or the letter 
of international ethical guidelines. 
sÈ 6ULNERABLEÈPOPULATIONSÈSUCHÈASÈSEXÈ
workers, may be subject to unjust 
treatment by local health authorities 
during HIV surveillance initiatives.
sÈ #ONDUCTINGÈ5!4ÈINÈETHICALLYÈANDÈ
epidemiologically sound ways in 
low-income countries requires a 
multifaceted approach including 
local capacity building, community 
engagement, and increased access to 
HIV and STI testing.
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halted UAT in these settings in 1995 
[1,7].
We believe that while UAT in 
itself is valuable and ethical, such 
surveillance can be conducted in 
ethically questionable ways in certain 
circumstances. In what follows, we will 
briefly compare international ethical 
guidelines on UAT with ethical and 
public health challenges encountered 
with HIV sentinel surveillance in sub-
Saharan Africa, among populations 
usually targeted by UAT efforts. 
Accompanying this discussion, 
we propose practical approaches, 
informed by field research in southern 
Africa, to improve the quality of HIV 
surveillance data, strengthen the ethics 
of surveillance activities, and enhance 
the capacity of public health systems. 
The Ethical Justification of UAT
Surveying the scientific literature, 
the ethical justification for the 
practice of UAT appears to consist 
in (1) the greater epidemiological 
utility of “unconsented” testing 
through avoidance of selection 
and participation bias; (2) the 
confidentiality protections afforded by 
anonymous, unlinked testing; (3) the 
fact that the residual blood collected 
for other purposes would be discarded 
anyway and no one is harmed by its use; 
and (4) the view that UAT takes place 
as part of a response to a public health 
emergency [8].
In developed world settings, these 
ethical conditions are commonly 
fulfilled, though the appropriateness 
of these conditions themselves merits 
independent ethical scrutiny [9]. The 
situation in developing countries is 
more obscure. In our own experience, 
for example, agencies conducting UAT 
in developing countries may collect 
residual blood from syphilis testing 
services they have temporarily set up 
to facilitate HIV surveillance. Similar 
experiences have been reported in 
Ethiopia: syphilis screening has been 
done only during the months when 
HIV sentinel surveillance is carried 
out, causing anxiety among women at 
antenatal care sites [10]. This follows 
neither the letter nor the spirit of 
WHO/UNAIDS guidelines, which 
state: “Unlinked anonymous HIV 
testing (without informed consent) 
is only conducted in clinic settings 
where blood is collected regularly 
for other purposes (usually syphilis 
testing)” [11]. If syphilis testing is 
offered opportunistically to obtain 
blood for surveillance purposes, then 
the primary purpose of the blood draw 
is not syphilis testing but surveillance, 
and consent should be obtained. For 
even if some patients benefit from 
syphilis testing, nondisclosure of the 
motivations of health surveillance 
agencies may have a negative impact 
on community trust and future disease 
control efforts. International agencies 
designing and implementing UAT 
that want to avoid the requirement 
of informed consent and comply 
with existing guidelines should either 
restrict conduct of their activities 
to well-functioning clinics (and risk 
poor generalizability of the results) or 
assume responsibility for strengthening 
or establishing clinics that can provide 
basic services and sustainably function 
as HIV sentinel sites. 
Debates about the conduct of UAT 
leads to questions about decision 
makers and decision processes. 
According to WHO/UNAIDS 
guidelines, UAT activities should 
be reviewed by a national ethics 
review board and involve a process 
of community consultation [2]. It 
is unclear that there is substantial 
public awareness globally of UAT or 
inclusive discussions about different 
approaches to surveillance. The 
situation is complicated by national 
ethics committees in resource-
poor countries being nonexistent, 
nascent, underfunded, or operating 
with guidelines better suited for 
biomedical research than public health 
surveillance. There is also the issue of 
unequal power: while WHO/UNAIDS 
state that surveillance approaches 
should depend on the epidemiological, 
health system, and community context, 
they acknowledge that national AIDS 
control programs in developing 
countries may fear loss of funding if 
local ethical concerns are raised about 
the conduct of UAT [2]. 
We see three broad strategies to 
harmonize quality surveillance with 
ethical concerns. First, justifications 
for unlinked, anonymous HIV 
testing should be reviewed in local 
contexts with local stakeholders. 
The justifications should be directly 
addressed in surveillance protocols, 
discussed with local ethics review 
boards, and communicated in 
community awareness meetings. 
Second, one ethical concern 
surrounding UAT—namely that 
persons whose blood tests positive for 
HIV do not know their HIV status—
could be addressed by providing 
confidential voluntary testing in close 
conjunction with UAT activities. Local 
stakeholders should play a central 
role in designating where such testing 
should best take place and whether 
it should take the form of “opt out” 
or “opt in” testing. Third, gaining 
local approval for HIV surveillance 
activities is important, but insufficient. 
Given the existing power imbalances 
between international agencies and 
developing countries, gaining local 
approval for surveillance activities can 
be relatively easy. Beyond approval lies 
the fundamental ethical requirement 
to strengthen in-country capacity in 
epidemiological surveillance, ethics, 
and health care systems. 
The Ethics of Implementing UAT
Elsewhere, we have discussed 
“implementation ethics,” i.e., 
the ethical issues arising from 
the implementation of proven 
interventions or programs, as 
distinguished from research ethics 
or clinical ethics [12]. UAT can be 
regarded as a proven program: it has 
been used successfully since 1990 in the 
United Kingdom, where 5 million tests 
were performed without a single breach 
in confidentiality [13]. In the United 
States, the program is considered by 
public health professionals to have 
provided an invaluable window on the 
HIV epidemic [1].
A key ethical question is to 
what extent these successes can be 
reproduced within fragile health 
systems in developing countries. One 
small example from our own field 
experience evokes some of the larger 
challenges. Two midwives were assisting 
with blood collection from sex workers 
at an HIV serosurveillance site. The 
midwives knew that a woman’s HIV 
test was positive, because the blood 
was collected in the same room where 
behavioral interviews and HIV testing 
took place. The test tubes containing 
blood were labeled to achieve 
unlinking, but the lab technician 
remembered the person whose blood 
was collected. The midwives reported 
the woman’s name to members of the 
local organization that provides care 
to sex workers, because they thought PLoS Medicine  |  www.plosmedicine.org 0032 January 2009  |  Volume 6  |  Issue 1  |  e1000004
the woman needed counseling and 
referral to care. The significance of 
this single incident goes beyond that 
of a protocol violation. Even in the 
United States, there is not always a 
clear recognition among the lay public 
or health professionals of the public 
health significance of surveillance, with 
a related inability (or unwillingness) 
to distinguish between the clinical 
context of HIV case finding and public 
health context of HIV surveillance 
[3]. Throughout history, doctors 
and nurses have found it difficult to 
transcend their concerns for individual 
patients and embrace the value of 
population-level surveillance [1]. In 
developing countries, such difficulties 
may be aggravated by the shortage of 
health staff, lack of adequate training, 
irregular medical supply chains, 
inadequate operating procedures, and 
poor communication between local 
clinics and public health authorities 
[14–20].
In some approaches to HIV 
surveillance, both behavioral data and 
blood are collected from participants. 
UNAIDS/WHO guidelines state that 
if UAT is used in HIV serosurveillance 
activities, “[n]o additional 
information should be requested 
from the participant; only the socio-
demographic or clinical information 
required on the clinic form should be 
collected” [11]. In our experiences, 
however, behavioral questions of 
interest to regional health authorities 
are sometimes included within HIV 
surveillance. For example, pregnant 
women may be asked sexual behavior 
questions, including sexual contacts 
with persons of another nationality, in 
regions where foreigners are suspected 
of disproportionally transmitting HIV. 
Such questions are not routinely asked, 
and their clinical relevance is doubtful 
at best. At worst, such questions are 
gratuitous invasions of privacy that may 
raise community suspicions towards 
public health interventions. 
We suggest three strategies to 
improve confidentiality of HIV 
results and limit potential abuses that 
may occur during UAT-based HIV 
surveillance. First, the importance 
of surveillance, and the distinction 
between HIV case finding and 
HIV surveillance, must be clearly 
communicated to everyone on the 
front line of participant interaction 
and sera collection. Second, field 
conditions at each sentinel site should 
be reviewed, and detailed site-specific 
operational procedures should be 
developed to allow genuine unlinked 
anonymous HIV testing. Third, 
protocol enforcement mechanisms 
should be established, including 
independent monitoring boards, field 
supervisions, and requirements for 
scheduled written reports. Appropriate 
training of all persons involved in HIV 
surveillance (national and local public 
health authorities, and clinic staff) is 
essential for optimal and responsible 
implementation.
UAT in Pregnant Women
Pregnant women are a special target 
group for HIV surveillance activities 
in the developing world. Access to 
women who attend antenatal clinics is 
usually easy, and pregnant women may 
be fairly representative of the sexually 
active adult population [21]. Women 
participating in UAT at antenatal 
clinics may have access to diagnostic 
HIV testing, which can alleviate some 
of the ethical concerns surrounding 
the practice of UAT. However, access 
to antiretroviral drugs in developing 
countries is increasing through 
initiatives like PEPFAR and the Global 
Fund. Such developments raise ethical 
concerns similar to those encountered 
in the United States, namely that UAT 
without consent may be regarded as 
unethical in areas with access to HIV 
prophylaxis and treatment. This could 
lead to accusations of ethical double 
standards: while UAT among pregnant 
women has been discontinued on 
ethical grounds in the United States, 
international agencies still support 
UAT at antenatal clinics in developing 
countries where antiretroviral drugs are 
locally available. 
In the background of this ethical 
discussion is another debate about the 
current and future utility of UAT at 
antenatal care sites. As prevention of 
mother-to-child transmission of HIV 
programs are increasingly implemented 
and strengthened in developing 
countries, and greater use is made of 
general population-based behavioral 
surveys incorporating HIV testing, 
the need for unlinked anonymous 
testing may be gradually phased out, 
along with its associated ethical issues 
[22]. For ethical and methodological 
reasons, the days of UAT among 
pregnant women in developing 
countries may be numbered. Local 
stakeholders need to be centrally 
involved in the decision making 
processes that determine where, when, 
and why this shift in HIV surveillance 
approach should take place, and 
what alternatives should be pursued, 
keeping in mind that population-based 
approaches have complex ethical 
challenges of their own [23]. 
UAT in Patients Seeking Care for 
Sexually Transmitted Infections in 
Public Clinics
In many settings in sub-Saharan Africa, 
relatively few persons with symptoms 
suggestive of sexually transmitted 
infections (STIs) seek care in public 
clinics [24]. Since antibiotics can often 
be purchased without prescription, 
persons who have STIs may prefer self-
treatment or consulting traditional 
healers or private physicians rather 
than treatment at public clinics. To 
increase participation of STI patients 
in public clinic–based HIV surveillance 
efforts, inducements (such as free care 
or new/additional medical services) 
are sometimes used. An anecdote raises 
broader concerns about this strategy. In 
a region where syphilis is common but 
testing is not systematically performed 
in public clinics, radio advertisements 
invited individuals to come to a public 
STI clinic for free testing. People 
flocked to the clinic. However, blood 
specimens were not transported to 
the central laboratory for testing due 
to deficient planning and follow-up 
between central and local public health 
staff. The frozen sera remained stored 
for several months at the local STI 
clinic. The clinic staff and patients were 
frustrated by the unavailability of the 
test results, and it is not known whether 
the residual sera were actually used for 
surveillance and ended up benefitting 
the communities in question.
The anecdote suggests that efforts 
to increase demand for STI testing for 
HIV surveillance purposes must be 
coupled with mechanisms enabling 
those tested to receive their STI results. 
But the larger question is whether 
such “inducements” are ethically 
acceptable. Is it justified to induce 
potential STI patients to a clinic with 
the primary purpose of using their 
residual blood, without their consent, 
for HIV surveillance? What would be 
the likely reaction of those tested for 
STIs, if they discovered this? Can such PLoS Medicine  |  www.plosmedicine.org 0033 January 2009  |  Volume 6  |  Issue 1  |  e1000004
responses be dismissed as irrational or 
based on public ignorance about the 
need for HIV surveillance? Inducing 
individuals to come to the STI clinic 
for free testing may additionally 
bias the results and defeat the HIV 
surveillance purpose. This example 
highlights the importance of regularly 
reviewing methodological and ethical 
justifications for UAT with key local 
stakeholders and ethical review boards, 
and exploring alternative approaches 
that can generate quality data with less 
risk to public trust in HIV prevention 
and control efforts. 
UAT among Sex Workers 
Obtaining meaningful sentinel 
surveillance data representative of 
the sex worker populations requires 
knowledge of these women’s health-
seeking behaviors and the institutions 
that provide sex workers with STI 
prevention and treatment services. 
However, sex workers, being a highly 
stigmatized group, may be reluctant 
to seek STI care at public clinics. 
Surveillance agencies attempting to 
gain access to this “hard-to-reach” 
population may enter into ethically 
murky territory. Two examples:
In our field research, local public  1.
health authorities were instructed 
to provide about 300 serum samples 
from sex workers for unlinked, 
anonymous surveillance in public 
health clinics. However, since few 
sex workers attend these clinics, 
an organization providing STI 
prevention and care services for sex 
workers was asked to collaborate in 
surveillance activities. The sex worker 
organization’s routine procedures 
included syphilis testing by rapid 
plasma reagin (RPR) every three 
months, except when women tested 
positive by RPR and were effectively 
treated, in which case they were 
retested six months later. This 
procedure conflicted with the local 
health authority’s desire to collect 
the required number of samples 
in a short time span. Local health 
authorities pressured the sex worker 
organization to perform blood 
draws with women not scheduled 
to have RPR tests according to 
routine procedures. The sex worker 
organization insisted that, according 
to their procedures and international 
guidelines, such blood collection 
required informed consent. 
However, the priorities of local 
public health authorities ultimately 
prevailed: blood was drawn for HIV 
surveillance without consent. 
In Bangladesh, there have been  2.
a number of negative incidents 
reported about HIV surveillance 
among sex workers. Unofficial 
HIV testing of sex workers led to 
the incarceration of sex workers 
through breaches of confidentiality. 
Dissemination of surveillance results 
by public health officials led to social 
welfare agencies and police forcefully 
evicting women from the surveyed 
brothels, spreading them through 
the city and compromising existing 
HIV prevention efforts [25].
There are additional concerns 
about social justice. Sex work is either 
illegal or socially undesirable in most 
countries. Special care must be taken in 
order that surveillance data collection 
or dissemination has a positive and 
lasting impact on this vulnerable group 
rather than posing additional burdens. 
Supportive collaborations between 
sex workers, sex worker organizations, 
gatekeepers (such as brothel owners 
and pimps), law enforcement 
authorities, Ministries of Women’s 
Affairs, local human rights groups, and 
agencies planning surveillance activities 
can usefully customize epidemiological 
methods to the local context [25], 
and can also enable stakeholders 
to respond appropriately to ethical 
concerns surrounding UAT of sex 
workers. Such consultations may also 
help with the question of whether (and 
how much) behavioral data should 
be collected during surveillance, and 
the associated challenges of gaining 
meaningful informed consent and 
offering noncoercive inducements 
during behavioral surveillance with low-
income, low-literacy participants. 
Conclusion
Attempts to implement 
methodologically and ethically sound 
surveillance practices currently 
encounter a number of significant 
challenges that may be widespread 
and under-reported in the developing 
world. Of the 167 HIV surveillance 
systems for which data were collected 
worldwide, one analysis found only 47 
of these programs (28%) adequate in 
terms of the frequency and timeliness 
of data collection, the appropriateness 
of the populations under surveillance, 
the consistency of sites, locations, and 
groups being measured over time, and 
the coverage and representativeness 
of those groups to measure adult HIV 
prevalence [26]. Effective and ethically 
responsible disease surveillance is a 
dynamic, multi-stakeholder process 
involving a wide array of evolving 
factors, including: current state of the 
epidemic; condition of the local public 
health and medical systems; prevalence 
of adequately trained health staff; 
knowledge of especially vulnerable 
populations; maintenance of disease 
registries; capacity in local ethics review; 
availability of HIV testing, treatment, 
prevention, and support services; 
political climate; and traditional 
cultural values. Without significant, 
targeted surveillance investment 
and capacity building in developing 
countries, important data from the 
HIV/AIDS epidemic may fall below the 
“radar of public health” while ethical, 
epidemiological, and public health 
system problems continue to linger.  
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